CAMP4 Therapeutics Corporation (NASDAQ:CAMP) Sees Large Decrease in Short Interest

CAMP4 Therapeutics Corporation (NASDAQ:CAMP) was the target of a large decline in short interest in the month of March. As of March 31st, there was short interest totaling 414,235 shares, a decline of 14.2% from the March 15th total of 483,060 shares. Based on an average daily volume of 128,124 shares, the days-to-cover ratio is presently 3.2 days. Approximately 1.2% of the shares of the company are short sold.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on CAMP. Rodman & Renshaw began coverage on shares of CAMP4 Therapeutics in a report on Tuesday. They set a “buy” rating and a $7.00 price target for the company. Weiss Ratings restated a “sell (e+)” rating on shares of CAMP4 Therapeutics in a research note on Monday, December 29th. Leerink Partners boosted their price objective on CAMP4 Therapeutics from $8.00 to $9.00 and gave the stock an “outperform” rating in a research report on Thursday, April 2nd. Finally, Cantor Fitzgerald reissued an “overweight” rating on shares of CAMP4 Therapeutics in a report on Friday, March 6th. Five research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $8.60.

CAMP4 Therapeutics Stock Down 0.2%

Shares of CAMP stock opened at $4.49 on Friday. The stock has a 50-day simple moving average of $4.64 and a 200 day simple moving average of $4.52. The stock has a market capitalization of $233.12 million, a P/E ratio of -1.69 and a beta of 0.41. CAMP4 Therapeutics has a fifty-two week low of $1.30 and a fifty-two week high of $7.75.

CAMP4 Therapeutics (NASDAQ:CAMP) last issued its quarterly earnings results on Thursday, March 5th. The Wireless communications provider reported ($0.87) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.31) by ($0.56). The business had revenue of $0.35 million during the quarter. CAMP4 Therapeutics had a negative net margin of 2,298.54% and a negative return on equity of 162.49%. On average, sell-side analysts anticipate that CAMP4 Therapeutics will post -4.99 earnings per share for the current year.

Institutional Investors Weigh In On CAMP4 Therapeutics

Several large investors have recently modified their holdings of CAMP. 683 Capital Management LLC purchased a new stake in shares of CAMP4 Therapeutics during the fourth quarter valued at $775,000. Geode Capital Management LLC raised its holdings in CAMP4 Therapeutics by 457.0% during the 4th quarter. Geode Capital Management LLC now owns 336,293 shares of the Wireless communications provider’s stock worth $2,063,000 after buying an additional 275,922 shares during the period. Adage Capital Partners GP L.L.C. lifted its stake in CAMP4 Therapeutics by 11.3% during the fourth quarter. Adage Capital Partners GP L.L.C. now owns 2,181,679 shares of the Wireless communications provider’s stock valued at $13,374,000 after buying an additional 220,895 shares in the last quarter. Vivo Capital LLC boosted its holdings in shares of CAMP4 Therapeutics by 8.3% in the fourth quarter. Vivo Capital LLC now owns 4,246,568 shares of the Wireless communications provider’s stock worth $26,031,000 after buying an additional 325,000 shares during the period. Finally, Janus Henderson Group PLC increased its position in shares of CAMP4 Therapeutics by 35.9% in the fourth quarter. Janus Henderson Group PLC now owns 6,307,636 shares of the Wireless communications provider’s stock worth $38,807,000 after acquiring an additional 1,666,666 shares in the last quarter.

CAMP4 Therapeutics Company Profile

CalAmp Corp., a connected intelligence company, provides leverages a data-driven solutions ecosystem to people and organizations in the United States, Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and internationally. The company operates in two segments, Software & Subscription Services and Telematics Products. It provides CalAmp Telematics Cloud platform, such as cloud-based application enablement and telematics service platforms that facilitate integration of its own applications, as well as those of third parties, through open application programming interfaces; and software as a service application, as well as provides tracking and monitoring services within fleet management, supply chain integrity, and international vehicle location.